Published DateClear

Start Date

End Date

Category

• Pipeline2
• Business1

Organizations

• Bausch + Lomb80
• Eyes On Eyecare59
• Alcon, Inc.53
• American Optometric Association44
• Harrow35
• Glaukos31
• Topcon Healthcare26
• Regeneron25
• Coopervision23
• Aldeyra Therapeutics21

Tags

• IOP3
• Clinical Trials3
• Medical Device3
• Glaucoma2
• Glaucoma Management2
• FDA1
• Business Management1
• Glaucoma Surgery1
• Ocular Implants1
• Surgery1

• Organizations: Ciliatech✕

Clear all

Pipeline

FDA grants IDE approval to Ciliatech for glaucoma implant study

Clearance brings company closer to a clinical and regulatory pathway for the cilioscleral interpositioning device, designed to lower IOP in POAG.

Business

Ciliatech to open US subsidiary supporting clinical advancement of novel glaucoma device

Upcoming clinical trials to study the Intercil Uveal Spacer, a cilioscleral interpositioning device that reestablishes the natural uveoscleral outflow.

Pipeline

Ciliatech reports positive 36-month follow-up on glaucoma surgical implant

Results from SAFARI 1 and 2 studies demonstrate an IOP control of 8.0 mmHg and 70% reduction in medication dependence.